Users Online: 375 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 

RSACP wishes to inform that it shall be discontinuing the dispatch of print copy of JOACP to it's Life members. The print copy of JOACP will be posted only to those life members who send us a written confirmation for continuation of print copy.
Kindly email your affirmation for print copies to [email protected] preferably by 30th June 2019.


    Article Cited by others


Flupirtine : Clinical pharmacology

Harish S, Bhuvana K, Bengalorkar Girish M, Kumar T N

Year : 2012| Volume: 28| Issue : 2 | Page no: 172-177

   This article has been cited by
1 The ups and downs of alkyl-carbamates in epilepsy therapy: How does cenobamate differ?
Wolfgang Löscher,Graeme J. Sills,H. Steve White
Epilepsia. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Voltammetric Behaviour of Drug Molecules as a Predictor of Metabolic Liabilities
Hikari Fuchigami,Mandeep K. Bal,Dale A. C. Brownson,Craig E. Banks,Alan M. Jones
Scientia Pharmaceutica. 2020; 88(4): 46
[Pubmed]  [Google Scholar] [DOI]
3 Hulk-Like Urine: A Case of Green Urine Caused by Flupirtine Intoxication
Maria Vilela,Diana Fernandes,Tatiana Salazar,Augusto Duarte
Cureus. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Anti-nociceptive and anxiolytic effects of systemic flupirtine and its direct inhibitory actions on in vivo neuronal mechanical sensory responses in the adult rat anterior cingulate cortex
Yu Matsumoto,Yuji Fujino,Hidemasa Furue
Biochemical and Biophysical Research Communications. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic–ischemic injury
Dayalan Sampath,Philip M. Lam,Maddy Laoprasert,Michael J. Diaz,Nicolas Busquet,Andrew M. White,Marco I. Gonzalez,Yogendra H. Raol
Pediatric Research. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Liver Transplant Due to Flupirtine-Induced Acute Liver Failure
Felix Dondorf,Roland S. Croner,Hans-Michael Tautenhahn,Philipp Felgendreff,Michael Ardelt,Utz Settmacher,Falk Rauchfuss
Experimental and Clinical Transplantation. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Prescription pattern of drugs used for neuropathic pain and adherence to NeuPSIG guidelines in cancer
VishalK Singh,YashashriC Shetty,Naveen Salins,Parmanand Jain
Indian Journal of Palliative Care. 2020; 26(1): 13
[Pubmed]  [Google Scholar] [DOI]
8 Flupirtine use in the era of risk minimization measures
Abhijit S. Nair
Current Medical Research and Opinion. 2019; 35(8): 1479
[Pubmed]  [Google Scholar] [DOI]
9 Pharmacology and clinical applications of flupirtine: Current and future options
Kim Lawson
World Journal of Pharmacology. 2019; 8(1): 1
[Pubmed]  [Google Scholar] [DOI]
10 In vitro approach to elucidate the relevance of carboxylesterase 2 and N -acetyltransferase 2 to flupirtine-induced liver injury
Keigo Konishi,Tatsuki Fukami,Takuo Ogiso,Miki Nakajima
Biochemical Pharmacology. 2018; 155: 242
[Pubmed]  [Google Scholar] [DOI]
11 Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats
Madhoosudan Patil,Brock Matter,Yogendra Raol,David Bourne,Ryan Kelley,Uday Kompella
Pharmaceutics. 2018; 10(4): 281
[Pubmed]  [Google Scholar] [DOI]
12 Flupirtine
Abhijit S. Nair
Anesthesia & Analgesia. 2018; 126(4): 1425
[Pubmed]  [Google Scholar] [DOI]
13 In Response
Kanupriya Kumar
Anesthesia & Analgesia. 2018; 126(4): 1425
[Pubmed]  [Google Scholar] [DOI]
14 Amination of Phosphorodiamidate-Substituted Pyridines and Related N-Heterocycles with Magnesium Amides
Moritz Balkenhohl,Benjamin Heinz,Thomas Abegg,Paul Knochel
Organic Letters. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Prescribers’ compliance is part of benefit-risk assessment of medicines and it can lead to failure of risk minimization measures and withdrawals of medicines
Livia Puljak
Current Medical Research and Opinion. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
16 Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy
Dayalan Sampath,Robert Valdez,Andrew M. White,Yogendra H. Raol
Neuropharmacology. 2017; 123: 126
[Pubmed]  [Google Scholar] [DOI]
17 Chronic maladaptive pain in cats: A review of current and future drug treatment options
Derek Adrian,Mark Papich,Ron Baynes,Jo Murrell,B. Duncan X. Lascelles
The Veterinary Journal. 2017;
[Pubmed]  [Google Scholar] [DOI]
18 An update on emerging drugs for fibromyalgia treatment
Fabiola Atzeni,Maria Chiara Gerardi,Ignazio Francesco Masala,Alessandra Alciati,Alberto Batticciotto,Piercarlo Sarzi-Puttini
Expert Opinion on Emerging Drugs. 2017; 22(4): 357
[Pubmed]  [Google Scholar] [DOI]
19 Discovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-cell lymphoma 2 (Bcl-2)
Nihar Kinarivala,Ronak Patel,Rose-Mary Boustany,Abraham J. Al-Ahmad,Paul C. Trippier
Journal of Medicinal Chemistry. 2017;
[Pubmed]  [Google Scholar] [DOI]
20 Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats
Sean P. Nassoiy,Kenneth L. Byron,Matthias Majetschak
Journal of Biomedical Science. 2017; 24(1)
[Pubmed]  [Google Scholar] [DOI]
21 UPLC Method for Determination of Eight Flupirtine Impurities in Bulk Substance and Their Characterization by 1H NMR and ESI–MS
Dileep M. Bhosale,Anna Pratima G. Nikalje
Chromatographia. 2016;
[Pubmed]  [Google Scholar] [DOI]
22 Inhibition of KV7 Channels Protects the Rat Heart against Myocardial Ischemia and Reperfusion Injury
E. R. Hedegaard,J. Johnsen,J. A. Povlsen,N. R. Jespersen,J. A. Shanmuganathan,M. R. Laursen,S. B. Kristiansen,U. Simonsen,H. E. Botker
Journal of Pharmacology and Experimental Therapeutics. 2016; 357(1): 94
[Pubmed]  [Google Scholar] [DOI]
23 Potential drug therapies for the treatment of fibromyalgia
Kim Lawson
Expert Opinion on Investigational Drugs. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
24 Pharmacokinetics and disposition of flupirtine in the horse
M. Giorgi,V. De Vito,A. Poapolathep,R. Rychshanova,M. Sgorbini,H. Owen
The Veterinary Journal. 2016; 208: 76
[Pubmed]  [Google Scholar] [DOI]
25 Emerging potassium channel targets for the treatment of pain
Christoforos Tsantoulas
Current Opinion in Supportive and Palliative Care. 2015; 9(2): 147
[Pubmed]  [Google Scholar] [DOI]
26 Flupirtine attenuates chronic restraint stress-induced cognitive deficits and hippocampal apoptosis in male mice
Pengcheng Huang,Cai Li,Tianli Fu,Dan Zhao,Zhen Yi,Qing Lu,Lianjun Guo,Xulin Xu
Behavioural Brain Research. 2015; 288: 1
[Pubmed]  [Google Scholar] [DOI]
27 The indirect NMDAR inhibitor flupirtine induces sustained post-ischemic recovery, neuroprotection and angioneurogenesis
Hanna M. Jaeger,Jens R. Pehlke,Britta Kaltwasser,Ertugrul Kilic,Mathias Bähr,Dirk M. Hermann,Thorsten R. Doeppner
Oncotarget. 2015; 6(16): 14033
[Pubmed]  [Google Scholar] [DOI]
28 Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1
Werner Siegmund,Christiane Modess,Eberhard Scheuch,Karen Methling,Markus Keiser,Ali Nassif,Dieter Rosskopf,Patrick J. Bednarski,Jürgen Borlak,Bernd Terhaag
British Journal of Clinical Pharmacology. 2015; 79(3): 501
[Pubmed]  [Google Scholar] [DOI]
29 Flupirtine: Preliminary Pharmacokinetics in the Donkey
Mario Giorgi,Fulvio Laus,Virginia De Vito,Helen Owen,Amnart Poapolathep,Emanuele Paggi,Cecilia Vullo
Journal of Equine Veterinary Science. 2015;
[Pubmed]  [Google Scholar] [DOI]
30 Pharmacokinetic profiles of the analgesic drug flupirtine in cats
V. De Vito,B. Lebkowska-Wieruszewska,H. Owen,C.J. Kowalski,M. Giorgi
The Veterinary Journal. 2014;
[Pubmed]  [Google Scholar] [DOI]
31 Hypothalamic-Pituitary-Adrenocortical Axis Activity as a Potential Predictor for Withdrawal Symptoms in Addiction to Flupirtine, a Nonopiate Analgesic
Johannes M. Hennings,Marcus Ising,Torsten Klengel,Matthias Knop,Marcus C. Rosenhagen
Journal of Clinical Psychopharmacology. 2014; 34(6): e6
[Pubmed]  [Google Scholar] [DOI]
32 Dependence on Flupirtine
Maximilian Gahr,Roland W. Freudenmann,Markus A. Kölle,Carlos Schönfeldt-Lecuona
The Journal of Clinical Pharmacology. 2013; 53(9): 1003
[Pubmed]  [Google Scholar] [DOI]
33 Advances in the treatment of neuronal ceroid lipofuscinosis
Dolan Sondhi,Jonathan B Rosenberg,Benjamin G Van de Graaf,Stephen M Kaminsky,Ronald G Crystal
Expert Opinion on Orphan Drugs. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]
34 Flupirtine, a re-discovered drug, revisited
Istvan Szelenyi
Inflammation Research. 2013; 62(3): 251
[Pubmed]  [Google Scholar] [DOI]
35 Abuse liability of flupirtine revisited: Implications of spontaneous reports of adverse drug reactions
Maximilian Gahr,Roland W. Freudenmann,Bernhard J. Connemann,Christoph Hiemke,Carlos Schönfeldt-Lecuona
The Journal of Clinical Pharmacology. 2013; 53(12): 1328
[Pubmed]  [Google Scholar] [DOI]
36 Flupirtine, a re-discovered drug, revisited
Szelenyi, I.
Inflammation Research. 2013; 62(3): 251-258
[Pubmed]  [Google Scholar]
37 Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K + currents in motor neuron-like cells
Wu, S.-N. and Hsu, M.-C. and Liao, Y.-K. and Wu, F.-T. and Jong, Y.-J. and Lo, Y.-C.
Evidence-based Complementary and Alternative Medicine. 2012; 2012(148403)
[Pubmed]  [Google Scholar]
38 Evidence for Inhibitory Effects of Flupirtine, a Centrally Acting Analgesic, on Delayed Rectifier K+Currents in Motor Neuron-Like Cells
Sheng-Nan Wu,Ming-Chun Hsu,Yu-Kai Liao,Fang-Tzu Wu,Yuh-Jyh Jong,Yi-Ching Lo
Evidence-Based Complementary and Alternative Medicine. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]


Read this article